Clonally expanded EOMES

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

1. Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma.Nature communications · 2026
   Article
2. Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells.Science advances · 2026
   Article
3. Advanced drug delivery platforms targeting cellular senescence: A promising strategy for cancer therapy.Acta pharmaceutica Sinica. B · 2026
   Review
4. A unique CD4⁺ T cell subset expressing granzyme K is regulated by transcription factor EOMES and important for T cell-mediated intestinal inflammation.Nature immunology · 2026
   Article
5. Cytotoxic CD4Signal transduction and targeted therapy · 2026
   Review
6. EomesoderminImmunity · 2025
   Article
7. Single-cell insights into the role of T cells in B-cell malignancies.FEBS letters · 2025
   Review
8. Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential.Biomedicines · 2025
   Review
9. Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?Trends in immunology · 2025
   Review
10. A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML.Journal of translational medicine · 2025
    Article
11. The power of microRNA regulation-insights into immunity and metabolism.FEBS letters · 2025
    Review
12. The Human Bone Marrow May Offer an IL-15-Dependent Survival Niche for EOMESEuropean journal of immunology · 2025
    Article
13. Prognostic risk model of LIHC T-cells based on scRNA-seq and RNA-seq and the regulation of the tumor immune microenvironment.Discover oncology · 2024
    Article
14. CD4Trends in cancer · 2024
    Review
15. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.Cancer cell international · 2024
    Review
16. CTLs heterogeneity and plasticity: implications for cancer immunotherapy.Molecular cancer · 2024
    Review
17. Acquisition of suppressive function by conventional T cells limits antitumor immunity upon TScience immunology · 2023
    Article
18. DISCERN: deep single-cell expression reconstruction for improved cell clustering and cell subtype and state detection.Genome biology · 2023
    Article
19. Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker.World journal of oncology · 2023
    Article
20. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.Science advances · 2023
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

46 authors at 14 institutions in 2 countries.

Funding

Abstract

Indexed as